DELIVERED IN 2019-2021
LAB & cGMP SPACE DELIVERED
project value
years combined experience
clients served
communities implementing custom life science economic development strategies across the US
%
Repeat Clients 2020
%
Repeat Clients 2021
%
Repeat Clients To Date 2022
Owner's Representation & Project Management
Building Biotech + Creating Possibilities
Our team manages the full lifecycle of complex biotech buildings and lab spaces—helping clients create possibilities by providing unique perspectives and applying creative and novel approaches.
“The Facility Logix team truly becomes a part of their client’s [internal] teams. They are transparent, work to build relationships, and are dedicated to the success of the project.”
Trudy Burke
Eisai Inc.
Feasibility Studies
Building Biotech + Imagining Possibilities
Our team provides unmatched market research and insight to public, private, and non-profit clients seeking to drive economic development—painting the canvas of possibilities for the creation of a communities of innovation.
Innovative Facility Marketing Solutions
Building Biotech + Showcasing Possibilities
Our team leverages its deep market knowledge and life sciences building expertise to provide sound and innovative business development and marketing solutions that showcase the possibilities of owner’s and real estate broker’s facilities to attract biotech occupants.
Our Clients
Our News
MATURING LIFE SCIENCE MARKETS: NEW YORK REGION
In the past several years, Facility Logix has expanded into the New York market and has established a presence there with strong consultant and company relationships.
Maturing U.S. Life Science Markets: Maryland
In our last post we discussed the emerging market of Philadelphia and its recent life sciences boom, thanks to significant federal and increasing private sector funding, leading to increased R&D activity and commercialization opportunities. This post will discuss...
MATURING LIFE SCIENCE MARKETS: GREATER PHILADELPHIA
As the high cost of living and limited lab space creates challenges for crowded life science markets, there are many emerging markets nationally that present alternative options where companies can expand or relocate. One example is the Greater Philadelphia market.